T80.319D ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter

Name of the Condition

• ABO incompatibility with hemolytic transfusion reaction, unspecified, subsequent encounter.

Summary

This condition describes a hemolytic transfusion reaction due to ABO incompatibility, occurring during a subsequent encounter. It involves the destruction of red blood cells from an incompatible transfusion, leading to systemic effects. The reaction is driven by pre-existing antibodies in the recipient that target donor red blood cell antigens, resulting in hemolysis and potential complications.

Causes

ABO incompatibility reactions result from transfusing blood or blood products with ABO antigens that do not match the recipient's blood type. This mismatch triggers an immune response, where the recipient's antibodies bind to donor red blood cells, causing their destruction (hemolysis). The reaction can involve red blood cells, plasma, or platelets if ABO compatibility is not maintained.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or icterus

Diagnosis

Diagnosis involves clinical assessment of transfusion reaction symptoms, laboratory tests (e.g., direct antiglobulin test, bilirubin levels, haptoglobin), and confirmation of ABO incompatibility. Documentation must specify the reaction type and subsequent encounter status.

Treatment Options

• Immediate cessation of the transfusion
• Supportive care (e.g., fluids, vasopressors)
• Monitoring for organ dysfunction
• Management of hemolysis (e.g., renal protection)
• Addressing underlying complications as needed

Prognosis and Follow-Up

Prognosis depends on the severity of hemolysis and organ involvement. Subsequent encounters require ongoing monitoring for delayed complications, such as renal impairment or recurrent hemolysis. Follow-up may include repeat laboratory testing and clinical evaluation.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or hemodynamic instability
• Multi-organ dysfunction
• Death (in severe cases)

Lifestyle & Prevention

• Ensure accurate ABO typing and crossmatching before transfusion
• Verify blood product compatibility and labeling
• Use electronic systems to reduce human error
• Educate staff on transfusion protocols
• Implement quality checks for blood product administration

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur, such as fever, chills, pain, or changes in urine color, especially after a blood transfusion.

Tips for Medical Coders

Document the specific encounter type (subsequent) and confirm the reaction is ABO-related with hemolysis. Ensure clinical notes support the unspecified nature of the reaction and subsequent encounter status. Code T80.319D is used when the reaction is not further specified and occurs during a subsequent encounter.